Wei Zheng
Fondateur chez Suzhou Connect Biopharma Co. Ltd.
Postes actifs de Wei Zheng
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Suzhou Connect Biopharma Co. Ltd.
 Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Directeur/Membre du Conseil | 02/05/2012 | - |
| Directeur Général | 02/05/2012 | - | |
| Fondateur | 02/05/2012 | - |
Historique de carrière de Wei Zheng
Formation de Wei Zheng
| University of California, Davis | Doctorate Degree |
Statistiques
Internationale
| Chine | 2 |
| Etats-Unis | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Suzhou Connect Biopharma Co. Ltd.
Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Health Technology |
